Logo image of SNYR

SYNERGY CHC CORP (SNYR) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:SNYR - US87165D2080 - Common Stock

1.82 USD
+0.01 (+0.55%)
Last: 1/13/2026, 4:10:03 PM

SNYR Key Statistics, Chart & Performance

Key Statistics
Market Cap20.48M
Revenue(TTM)34.59M
Net Income(TTM)2.58M
Shares11.25M
Float4.90M
52 Week High4.46
52 Week Low1.3
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)0.29
PE6.28
Fwd PE5.76
Earnings (Next)03-30 2026-03-30
IPO2013-11-08
Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS IndustryGroupHousehold & Personal Products
GICS SubIndustryPersonal Care Products


SNYR short term performance overview.The bars show the price performance of SNYR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

SNYR long term performance overview.The bars show the price performance of SNYR in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of SNYR is 1.82 USD. In the past month the price increased by 0.55%. In the past year, price decreased by -55.28%.

SYNERGY CHC CORP / SNYR Daily stock chart

SNYR Competitors/Peers

The largest stocks on the US markets in the "Personal Care Products" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
EL ESTEE LAUDER COMPANIES-CL A 68.67 41.57B
KVUE KENVUE INC 15.9 32.59B
ELF ELF BEAUTY INC 28.34 5.20B
IPAR INTERPARFUMS INC 16.75 2.81B
COTY COTY INC-CL A 16.79 2.79B
BRBR BELLRING BRANDS INC 10.64 2.76B
OLPX OLAPLEX HOLDINGS INC 20.63 1.10B
EPC EDGEWELL PERSONAL CARE CO 7.26 856.72M
BNKK BONK INC N/A 497.09M
NUS NU SKIN ENTERPRISES INC - A 7.7 518.21M
NATR NATURES SUNSHINE PRODS INC 23.84 392.18M
USNA USANA HEALTH SCIENCES INC 10.36 371.27M

About SNYR

Company Profile

SNYR logo image Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company is headquartered in Westbrook, Maine and currently employs 21 full-time employees. The company went IPO on 2013-11-08. The firm's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. The company has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.

Company Info

SYNERGY CHC CORP

865 Spring St

Westbrook MAINE US

Employees: 21

SNYR Company Website

Phone: 16159399004

SYNERGY CHC CORP / SNYR FAQ

Can you describe the business of SYNERGY CHC CORP?

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company is headquartered in Westbrook, Maine and currently employs 21 full-time employees. The company went IPO on 2013-11-08. The firm's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. The company has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.


What is the stock price of SYNERGY CHC CORP today?

The current stock price of SNYR is 1.82 USD. The price increased by 0.55% in the last trading session.


Does SNYR stock pay dividends?

SNYR does not pay a dividend.


What is the ChartMill technical and fundamental rating of SNYR stock?

SNYR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


What is the GICS sector and industry of SNYR stock?

SYNERGY CHC CORP (SNYR) operates in the Consumer Staples sector and the Personal Care Products industry.


What is the market capitalization of SNYR stock?

SYNERGY CHC CORP (SNYR) has a market capitalization of 20.48M USD. This makes SNYR a Nano Cap stock.


What is the Short Interest ratio of SYNERGY CHC CORP (SNYR) stock?

The outstanding short interest for SYNERGY CHC CORP (SNYR) is 0.35% of its float.


SNYR Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to SNYR. When comparing the yearly performance of all stocks, SNYR is a bad performer in the overall market: 93.48% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SNYR Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to SNYR. SNYR has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SNYR Financial Highlights

Over the last trailing twelve months SNYR reported a non-GAAP Earnings per Share(EPS) of 0.29. The EPS decreased by -67.6% compared to the year before.


Industry RankSector Rank
PM (TTM) 7.46%
ROA 12.47%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-88.04%
Sales Q2Q%12.4%
EPS 1Y (TTM)-67.6%
Revenue 1Y (TTM)-18.57%

SNYR Forecast & Estimates

7 analysts have analysed SNYR and the average price target is 7.14 USD. This implies a price increase of 292.31% is expected in the next year compared to the current price of 1.82.

For the next year, analysts expect an EPS growth of -25% and a revenue growth 0.72% for SNYR


Analysts
Analysts82.86
Price Target7.14 (292.31%)
EPS Next Y-25%
Revenue Next Year0.72%

SNYR Ownership

Ownership
Inst Owners14.58%
Ins Owners6.97%
Short Float %0.35%
Short Ratio0.37